N※N

Howard County Introduces Tivicay, the Latest HIV Pre-Exposure Prophylaxis, for Residents

78

  //health-fitness.news-articles.net/content/2025/ .. -hiv-pre-exposure-prophylaxis-for-residents.html
  Published in Health and Fitness on Thursday, December 4th 2025 at 15:15 GMT by Patch

• 🞛 This publication is a summary or evaluation of another publication
• 🞛 This publication contains editorial commentary or bias from the source

2025-12-04 224 x 224 / 5142 Bytes

2025-12-04 185 x 224 / 10787 Bytes

2025-12-04 224 x 224 / 7977 Bytes

2025-12-04 224 x 224 / 5048 Bytes

New HIV Drug Now Available Through Howard County Health Department: What Residents Need to Know

The Howard County Health Department (HCHD) has announced the rollout of a new HIV pre‑exposure prophylaxis (PrEP) medication, marking a significant step forward in the county’s ongoing effort to reduce new HIV infections. The move brings the most recent FDA‑approved drug—Tivicay (tenofovir alafenamide/emtricitabine)—directly to the community, allowing local residents to access it through a streamlined process that builds on the county’s robust public‑health infrastructure.

Why the New Drug Matters

Tivicay is the latest entrant in the PrEP market, following the more widely known Truvada (tenofovir disoproxil fumarate/emtricitabine). While both drugs are highly effective, Tivicay offers several advantages:

• Lower Kidney and Bone Impact – Tenofovir alafenamide, the active ingredient in Tivicay, is associated with less renal toxicity and less effect on bone mineral density than the tenofovir disoproxil fumarate used in Truvada.
• Higher Efficacy in Some Populations – Clinical trials suggest that Tivicay may be more effective among people who have high levels of the virus in rectal tissue, a group that includes many men who have sex with men (MSM).
• Improved Convenience – The drug’s once‑daily dosing remains unchanged, but the more favorable side‑effect profile means fewer treatment interruptions.

The HCHD notes that the introduction of Tivicay aligns with CDC guidance, which encourages the use of the drug for individuals who meet criteria for PrEP but may be at risk of adverse effects from Truvada.

Who Can Qualify?

The health department follows the CDC’s PrEP eligibility criteria, which include:

• High‑Risk Sexual Behavior – Individuals who have had condomless receptive anal sex with partners of unknown or HIV‑positive status, or who are in serodiscordant relationships.
• Drug Use Concerns – People who inject drugs or have a history of using injection equipment.
• Other Risk Factors – Certain occupational exposures or individuals with a history of STI acquisition.

Potential users undergo a brief medical screening that assesses kidney function, liver health, and other baseline labs. If they meet the health criteria, they are offered the medication and instructed on adherence strategies.

How to Get Started

1. Book an Appointment – Residents can schedule a visit through the HCHD’s website or by calling the local health clinic. The department offers both in‑person and telehealth options for initial consultations.

2. Complete the Screening – At the appointment, patients receive a urine and blood test. The lab results determine whether the drug is safe for them.

3. Prescription and Pharmacy Pickup – If cleared, the HCHD’s Pharmacy Services will place a prescription for Tivicay. Residents can then pick up the medication from the county pharmacy network or use mail‑order services for convenience.

4. Follow‑Up Care – Regular check‑ins (every three to six months) monitor for side effects and ensure that PrEP remains an appropriate part of the patient’s prevention strategy.

The county has partnered with local community‑based organizations to raise awareness and to host informational webinars. The HCHD also collaborates with the Maryland Department of Health’s HIV Prevention Division, which offers a free HIV testing and counseling program that often dovetails with PrEP outreach.

Cost and Coverage

One of the most common concerns for people considering PrEP is affordability. HCHD’s new program offers several avenues for cost relief:

• Insurance Coverage – The drug is covered under many commercial plans and Medicaid. The department’s billing team can help patients verify benefits and submit paperwork.
• Manufacturer Assistance Programs – Tivicay’s manufacturer, Gilead Sciences, provides a patient assistance program that offers the drug at no cost to those who qualify based on income and insurance status.
• County Subsidies – For uninsured residents, the HCHD offers a sliding‑scale payment option that keeps the monthly cost well below the retail price.

The health department estimates that, with these options in place, the effective cost for most users will be less than $100 per month, far below the usual out‑of‑pocket expense for PrEP.

Community Response

The announcement has already sparked conversations in local forums and social media. Several residents have shared their stories about navigating the HIV prevention landscape. One local community activist noted, “Having Tivicay available right here in Howard County means that people who might have otherwise gone to the city for care can stay in the community that’s already supporting them.” Another user highlighted the importance of the county’s comprehensive approach, citing the ease of getting labs, counseling, and medication all in one place.

Healthcare providers also welcomed the initiative. Dr. Maria Lopez, a family physician at the county’s primary care clinic, explained, “The new drug expands our toolbox. It’s not just about reducing infection rates—it’s about empowering patients with choices that fit their health profiles.”

What’s Next?

The HCHD is not stopping at the drug rollout. The department plans to:

• Track Outcomes – A data collection initiative will monitor new HIV diagnoses and adherence rates among PrEP users to evaluate program effectiveness.
• Expand Outreach – Mobile testing units will be deployed in underserved neighborhoods to ensure equitable access.
• Educate the Public – An upcoming campaign will provide updated resources about PrEP, including a FAQ guide on the county website.

In addition to the county’s internal efforts, the article linked to the U.S. Centers for Disease Control and Prevention (CDC) guidance on PrEP. Readers can access the CDC’s detailed recommendations via the provided link, which offers a deeper dive into eligibility criteria and best practices.

Bottom Line

The Howard County Health Department’s new HIV drug availability marks a milestone for community health. With Tivicay’s superior safety profile, a clear, patient‑friendly process, and multiple financial support options, the county is setting a model for how local public‑health agencies can adapt to evolving medical options. Residents looking to reduce their HIV risk now have a new, more convenient, and affordable tool at their disposal—one that underscores the county’s commitment to safeguarding the health of every resident.